NCCN guidelines                         ®                          insights non–small cell lung cancer, version 5.2018 featured updates to the NCCN guidelines

David S. Ettinger; Dara L. Aisner; Douglas E. Wood; Wallace Akerley; Jessica Bauman; Joe Y. Chang; Lucian R. Chirieac; Thomas A. D’Amico; Thomas J. Dilling; Michael Dobelbower; Ramaswamy Govindan; Matthew A. Gubens; Mark Hennon; Leora Horn; Rudy P. Lackner; Michael Lanuti; Ticiana A. Leal; Rogerio Lilenbaum; Jules Lin; Billy W. Loo; Renato Martins; Gregory A. Otterson; Sandip P. Patel; Karen Reckamp; Gregory J. Riely; Steven E. Schild; Theresa A. Shapiro; James Stevenson; Scott J. Swanson; Kurt Tauer; Stephen C. Yang; Kristina Gregory; Miranda Hughes

doi:10.6004/jnccn.2018.0062

NCCN guidelines ^® insights non–small cell lung cancer, version 5.2018 featured updates to the NCCN guidelines

David S. Ettinger, Dara L. Aisner, Douglas E. Wood, Wallace Akerley, Jessica Bauman, Joe Y. Chang, Lucian R. Chirieac, Thomas A. D’Amico, Thomas J. Dilling, Michael Dobelbower, Ramaswamy Govindan, Matthew A. Gubens, Mark Hennon, Leora Horn, Rudy P. Lackner, Michael Lanuti, Ticiana A. Leal, Rogerio Lilenbaum, Jules Lin, Billy W. LooRenato Martins, Gregory A. Otterson, Sandip P. Patel, Karen Reckamp, Gregory J. Riely, Steven E. Schild, Theresa A. Shapiro, James Stevenson, Scott J. Swanson, Kurt Tauer, Stephen C. Yang, Kristina Gregory, Miranda Hughes

Research output: Contribution to journal › Review article › peer-review

404 Scopus citations

Abstract

The NCCN Guidelines for Non–Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC. These NCCN Guidelines Insights focus on recent updates to the targeted therapy and immunotherapy sections in the NCCN Guidelines. For the 2018 update, a new section on biomarkers was added.

Original language	English
Pages (from-to)	807-821
Number of pages	15
Journal	Journal of the National Comprehensive Cancer Network : JNCCN
Volume	16
Issue number	7
DOIs	https://doi.org/10.6004/jnccn.2018.0062
State	Published - Jul 1 2018

Keywords

Antineoplastic Agents, Immunological/pharmacology
Antineoplastic Combined Chemotherapy Protocols/pharmacology
Biomarkers, Tumor/genetics
Carcinoma, Non-Small-Cell Lung/drug therapy
Disease Progression
Drug Resistance, Neoplasm/genetics
Humans
Lung Neoplasms/drug therapy
Medical Oncology/standards
Molecular Targeted Therapy/methods
Mutation
Progression-Free Survival
Randomized Controlled Trials as Topic
Societies, Medical/standards
United States

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.6004/jnccn.2018.0062

Cite this

Ettinger, D. S., Aisner, D. L., Wood, D. E., Akerley, W., Bauman, J., Chang, J. Y., Chirieac, L. R., D’Amico, T. A., Dilling, T. J., Dobelbower, M., Govindan, R., Gubens, M. A., Hennon, M., Horn, L., Lackner, R. P., Lanuti, M., Leal, T. A., Lilenbaum, R., Lin, J., ... Hughes, M. (2018). NCCN guidelines ^® insights non–small cell lung cancer, version 5.2018 featured updates to the NCCN guidelines. Journal of the National Comprehensive Cancer Network : JNCCN, 16(7), 807-821. https://doi.org/10.6004/jnccn.2018.0062

@article{64e27c6cd20f4a4ba5f63d0e5cb6b458,

title = "NCCN guidelines {\textregistered} insights non–small cell lung cancer, version 5.2018 featured updates to the NCCN guidelines",

abstract = "The NCCN Guidelines for Non–Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC. These NCCN Guidelines Insights focus on recent updates to the targeted therapy and immunotherapy sections in the NCCN Guidelines. For the 2018 update, a new section on biomarkers was added.",

keywords = "Antineoplastic Agents, Immunological/pharmacology, Antineoplastic Combined Chemotherapy Protocols/pharmacology, Biomarkers, Tumor/genetics, Carcinoma, Non-Small-Cell Lung/drug therapy, Disease Progression, Drug Resistance, Neoplasm/genetics, Humans, Lung Neoplasms/drug therapy, Medical Oncology/standards, Molecular Targeted Therapy/methods, Mutation, Progression-Free Survival, Randomized Controlled Trials as Topic, Societies, Medical/standards, United States",

author = "Ettinger, {David S.} and Aisner, {Dara L.} and Wood, {Douglas E.} and Wallace Akerley and Jessica Bauman and Chang, {Joe Y.} and Chirieac, {Lucian R.} and D{\textquoteright}Amico, {Thomas A.} and Dilling, {Thomas J.} and Michael Dobelbower and Ramaswamy Govindan and Gubens, {Matthew A.} and Mark Hennon and Leora Horn and Lackner, {Rudy P.} and Michael Lanuti and Leal, {Ticiana A.} and Rogerio Lilenbaum and Jules Lin and Loo, {Billy W.} and Renato Martins and Otterson, {Gregory A.} and Patel, {Sandip P.} and Karen Reckamp and Riely, {Gregory J.} and Schild, {Steven E.} and Shapiro, {Theresa A.} and James Stevenson and Swanson, {Scott J.} and Kurt Tauer and Yang, {Stephen C.} and Kristina Gregory and Miranda Hughes",

note = "Publisher Copyright: {\textcopyright} JNCCN—Journal of the National Comprehensive Cancer Network.",

year = "2018",

month = jul,

day = "1",

doi = "10.6004/jnccn.2018.0062",

language = "English",

volume = "16",

pages = "807--821",

journal = "Journal of the National Comprehensive Cancer Network : JNCCN",

issn = "1540-1405",

publisher = "Cold Spring Publishing LLC",

number = "7",

}

Ettinger, DS, Aisner, DL, Wood, DE, Akerley, W, Bauman, J, Chang, JY, Chirieac, LR, D’Amico, TA, Dilling, TJ, Dobelbower, M, Govindan, R, Gubens, MA, Hennon, M, Horn, L, Lackner, RP, Lanuti, M, Leal, TA, Lilenbaum, R, Lin, J, Loo, BW, Martins, R, Otterson, GA, Patel, SP, Reckamp, K, Riely, GJ, Schild, SE, Shapiro, TA, Stevenson, J, Swanson, SJ, Tauer, K, Yang, SC, Gregory, K & Hughes, M 2018, 'NCCN guidelines ^® insights non–small cell lung cancer, version 5.2018 featured updates to the NCCN guidelines', Journal of the National Comprehensive Cancer Network : JNCCN, vol. 16, no. 7, pp. 807-821. https://doi.org/10.6004/jnccn.2018.0062

NCCN guidelines ^® insights non–small cell lung cancer, version 5.2018 featured updates to the NCCN guidelines. / Ettinger, David S.; Aisner, Dara L.; Wood, Douglas E. et al.
In: Journal of the National Comprehensive Cancer Network : JNCCN, Vol. 16, No. 7, 01.07.2018, p. 807-821.

Research output: Contribution to journal › Review article › peer-review

TY - JOUR

T1 - NCCN guidelines ® insights non–small cell lung cancer, version 5.2018 featured updates to the NCCN guidelines

AU - Ettinger, David S.

AU - Aisner, Dara L.

AU - Wood, Douglas E.

AU - Akerley, Wallace

AU - Bauman, Jessica

AU - Chang, Joe Y.

AU - Chirieac, Lucian R.

AU - D’Amico, Thomas A.

AU - Dilling, Thomas J.

AU - Dobelbower, Michael

AU - Govindan, Ramaswamy

AU - Gubens, Matthew A.

AU - Hennon, Mark

AU - Horn, Leora

AU - Lackner, Rudy P.

AU - Lanuti, Michael

AU - Leal, Ticiana A.

AU - Lilenbaum, Rogerio

AU - Lin, Jules

AU - Loo, Billy W.

AU - Martins, Renato

AU - Otterson, Gregory A.

AU - Patel, Sandip P.

AU - Reckamp, Karen

AU - Riely, Gregory J.

AU - Schild, Steven E.

AU - Shapiro, Theresa A.

AU - Stevenson, James

AU - Swanson, Scott J.

AU - Tauer, Kurt

AU - Yang, Stephen C.

AU - Gregory, Kristina

AU - Hughes, Miranda

N1 - Publisher Copyright: © JNCCN—Journal of the National Comprehensive Cancer Network.

PY - 2018/7/1

Y1 - 2018/7/1

N2 - The NCCN Guidelines for Non–Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC. These NCCN Guidelines Insights focus on recent updates to the targeted therapy and immunotherapy sections in the NCCN Guidelines. For the 2018 update, a new section on biomarkers was added.

AB - The NCCN Guidelines for Non–Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC. These NCCN Guidelines Insights focus on recent updates to the targeted therapy and immunotherapy sections in the NCCN Guidelines. For the 2018 update, a new section on biomarkers was added.

KW - Antineoplastic Agents, Immunological/pharmacology

KW - Antineoplastic Combined Chemotherapy Protocols/pharmacology

KW - Biomarkers, Tumor/genetics

KW - Carcinoma, Non-Small-Cell Lung/drug therapy

KW - Disease Progression

KW - Drug Resistance, Neoplasm/genetics

KW - Humans

KW - Lung Neoplasms/drug therapy

KW - Medical Oncology/standards

KW - Molecular Targeted Therapy/methods

KW - Mutation

KW - Progression-Free Survival

KW - Randomized Controlled Trials as Topic

KW - Societies, Medical/standards

KW - United States

UR - http://www.scopus.com/inward/record.url?scp=85049839389&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2018.0062

DO - 10.6004/jnccn.2018.0062

M3 - Review article

C2 - 30006423

AN - SCOPUS:85049839389

SN - 1540-1405

VL - 16

SP - 807

EP - 821

JO - Journal of the National Comprehensive Cancer Network : JNCCN

JF - Journal of the National Comprehensive Cancer Network : JNCCN

IS - 7

ER -